Vanda Pharmaceuticals (VNDA) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.38% |
| Dec 31, 2025 | -14.70% |
| Sep 30, 2025 | -3.32% |
| Jun 30, 2025 | -1.48% |
| Mar 31, 2025 | 0.61% |
| Dec 31, 2024 | 2.17% |
| Sep 30, 2024 | 3.14% |
| Jun 30, 2024 | 4.08% |
| Mar 31, 2024 | 5.17% |
| Dec 31, 2023 | 6.33% |
| Sep 30, 2023 | 7.22% |
| Jun 30, 2023 | 7.75% |
| Mar 31, 2023 | 8.76% |
| Dec 31, 2022 | 8.66% |
| Sep 30, 2022 | 8.75% |
| Jun 30, 2022 | 19.68% |
| Mar 31, 2022 | 21.72% |
| Dec 31, 2021 | 22.39% |
| Sep 30, 2021 | 23.58% |
| Jun 30, 2021 | 24.18% |
| Mar 31, 2021 | 24.70% |
| Dec 31, 2020 | 51.10% |
| Sep 30, 2020 | 50.03% |
| Jun 30, 2020 | 48.64% |
| Mar 31, 2020 | 48.12% |
| Dec 31, 2019 | 46.26% |
| Sep 30, 2019 | 45.87% |
| Jun 30, 2019 | 34.62% |
| Mar 31, 2019 | 31.29% |
| Dec 31, 2018 | 27.45% |
| Sep 30, 2018 | 21.45% |
| Jun 30, 2018 | 18.83% |
| Mar 31, 2018 | 16.51% |
| Dec 31, 2017 | -6.52% |
| Sep 30, 2017 | 396.96% |
| Jun 30, 2017 | 429.55% |
| Mar 31, 2017 | 82.79% |
| Dec 31, 2016 | 43.85% |
| Sep 30, 2016 | 37.21% |
| Jun 30, 2016 | 189.24% |
| Mar 31, 2016 | 166.75% |
| Dec 31, 2015 | 137.70% |
| Sep 30, 2015 | 111.84% |
| Jun 30, 2015 | 95.36% |
| Mar 31, 2015 | 78.25% |
| Dec 31, 2014 | 68.74% |
| Sep 30, 2014 | -69.56% |
| Jun 30, 2014 | -71.82% |
| Dec 31, 2013 | 5.36% |
| Dec 31, 2012 | -24.52% |